Tushar Patel – Pharmazone
View Detailed Executive Profile →Professional Overview
- Tushar Patel founded Pharmazone in June 2009, establishing the organization as a key player in the pharmaceutical industry.
- During the tenure at Pharmazone, significant strides were made in developing innovative pharmaceutical solutions aimed at improving patient outcomes.
- As CEO, Tushar Patel led the organization through numerous challenges in a competitive market, focusing on strategic partnerships and collaborations.
- Pharmazone gained recognition for its commitment to quality and compliance with regulatory standards, ensuring safe and effective products.
- Prior to founding Pharmazone, Tushar Patel served as a Project Manager at Veeda Clinical Research from April 2007 until June 2009, where valuable experience was gained in clinical trial management.
- The leadership at Pharmazone emphasized the importance of research and development, paving the way for innovative therapies and contributing to scientific advancements.
- Under Tushar Patel's guidance, Pharmazone expanded its operational capabilities and entered new markets, enhancing its global footprint.
- Active participation in industry conferences and forums was promoted, establishing Pharmazone as a thought leader in the pharmaceutical sector.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Veeda Clinical Research(OFFICIAL) | Project Manager | Apr 2007 – Jun 2009 |
| Pharmazone | CEO & Founder | Jun 2009 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Pharmazone corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Tushar Patel's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Pharmazone's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)